SLC2A1 and lung carcinoma: These findings indicate that indacaterol binds to GLUT1 protein and upregulates its expression, and may also influence tumor development by regulating the metabolism of lung cancer cells, however, the main mechanism by which indacaterol inhibits tumors remains unclear.